chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team, Program ID: Unknown. The reporter is the parent. A female patient in her 30's received BNT162b2 (BNT162B2), on 10Dec2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "hearing impaired" (unspecified if ongoing), notes: hearing impaired prior to getting the vaccine. She is in her 30's and it is congenital. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; manufacturer unknown), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 24Feb2022, outcome "unknown" and all described as "she tested positive for COVID-19 infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Feb2022) positive. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Based on the information available and temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The case will be reassessed once new information is available.
On the third day after I got the third dose of the vaccine I felt flushed and I had pain in my sides. I had no appetite, and my sense of taste was gone. I developed a dry cough and congestion. I tested Positive on the fifth day after the vaccine when I went to the hospital. My sense of taste has returned a little. My cough was constant until about a week later. Cough drops are helping. I got a fever of 38 degrees Celsius for several days. I do have autoimmune so I am not sure if I am the road to recovery. I am in quarantine in a Hotel currently.
Patient developed a rash on body and scalp 2 days after the immunization. His doctor's office was contacted and it was recommended that he take BENADRYL over-the-counter (AM).
Headache, Myalgia, Fever, achy, headache, fever 100.8 myalgias, legs rubbery, arm pain, generalized malaise, cold sweats w/ febrile illness, poor sleep Narrative:
This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine was administered to patient via subcutaneous route) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 28-Apr-2022, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine was administered to patient via subcutaneous route). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine was administered to patient via subcutaneous route) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments. Patient received 2nd booster dose. No concomitant medication was provided by reporter. No treatment medication was provided by reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2022: Follow up received included no new information.
Blanching macular rash to hip (L) (B) upper leg, abdomen, (L) arm. No vesicles, no papules, no target lesions. 2 days noted after vaccines. Started (L) hip (+) pruritus. Not on vaccine site.
cellulits,progressed to buttock abscess with fever and limp,hositalised, IV antibiotics and abscess incised,MRSA cultured. Varicella.
Pt received 2nd mening B vaccine on 11/21. The next day pt had a 1inch in diameter round raised area below the vaccine site on her left upper arm. It was a small lump and painful to touch. It was red and hot to touch. It's now been a week and pt complains that the arm is still tender but has returned to university. The lump is gone.
It began with redness that rapidly progress and ultimately, on the date seen (8/24/2016) was 17cm X 12 cm and most consistent with cellulitis. 99F temp, no fevers, chills, vomiting, diarrhea, or limp.
Vaccination adverse reaction; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction). At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Sep-2023: Live non-significant follow up received.
Admitted to the hospital 5/31/2022  for cough with fever, hypoxia and weakness. Tested COVID+ 5/31/2021.   He developed a bacterial superinfection and non-STEMI. He required mechanical ventilation, multiorgan failure due to cryptogenic shockand suspected pulmonary embolus.  He expired 6/12/2021
Herpes Zoster (shingles) with deep scarring on arm and still sore and scabbing.
Received Pfizer vaccine as 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine as 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 03-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine as 2nd dose). On 03-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine as 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not reported.
pt recv vax 7AUG95 410PM & exp episode of syncope 4115PM in waiting room area-falling back against door & sliding to floor-no apparent injuries; c/o sore head lt side;
brain fog, weakness in tongue, decreased sensation in side of mouth, decreased ability to swallow, eyes briefly watering/burning, surface of tongue became white, intermittent tingling in legs, pressure in head and inside of nose, intermittent tightness in chest
No additional AE reported; PROQUAD was administered to a patient after a temperature excursion.; This spontaneous report has been received from vaccine coordinator referring to a patient of unknown age and gender. No information regarding the patients' concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided  On 28-DEC-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD),0.5 ml (lot number # U022728 has been verified to be a valid lot number, expiration date reported and established as 16-JAN-2023,) after a temperature excursion (product storage error) (doses, vaccination schemes, routes of administration and anatomical site of vaccination were not reported), as prophylaxis.   The vaccine was exposed to a temperature of 8.1 C, for a time frame of 2 hours 58 minutes and 0 seconds. There was no information regarding previous temperature excursions.   No additional adverse event was reported.
slight fever, chills, headache, body aches and back pain for approx 12 hrs
Pt developed fever to 103 the evening after receiving vaccine.  Persisted to 102 in AM.  Mother treated with Tylenol and Motrin.  Appears well when fever down.
Unpleasant taste - slightly metallic, bad taste on roof of mouth - lasted for 2 days
New menstruation patterns. Specifically, very heavy menstruation (large glob of blood) that soaked through a tampon in an hour (not typical for me) and soaked my pants without cramping. What came out looked like a large blood clot (similar to a miscarriage). Later, my period suddenly stopped which is also highly unusual. After looking at medical journals and information reported from doctors, I am not the only female with post-menstruation issues after the COVID vaccine.
adult dose given to pediatric patient; adult dose given to pediatric patient; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 3-year-old female patient who received HBV (Engerix B adult) (batch number LG5RN, expiry date 20th August 2022) for prophylaxis.   On 18th February 2022, the patient received Engerix B adult (intramuscular). On 18th February 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK Receipt Date: 21-APR-2022 Reporter's comment: The reporter was nurse from pediatric clinic and stated, the patient received an adult Engerix-B dose. No further information was known.  The reporter consented to follow up. Additional Supportive Information: The pediatric patient received an adult Engerix-B dose, which led to adult product administered to child and overdose.
After my 1st dose I started having symptoms that felt like RA. It was worse in my feet knees and hands. After 2nd dose,  on 05/08/2021- Lot# 027C21A,  the symptoms became worse. I saw a Podiatrist and the pain specialist sent me to a rheumatologist. The doctor said the symptoms were post COVID Symptoms system got worse and I was from back in 01/2021. I was hospitalized because I had a abdominal infection. The vaccine has ruined my immune system. I am on 8 medications now due to this happening  I am currently seeing a infectious disease doctor this week. My blood pressure is in the life threatening range now. I have a major decline in my health I am completely a different person in my health than I was a year ago.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 09-DEC-2015 at 18:58, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 6.2 and 4.7 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
SORE ARM; STIFF MUSCLES; CHILLS; FEVER; HEADACHES; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES). At the time of the report, PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL STIFFNESS (STIFF MUSCLES), CHILLS (CHILLS), PYREXIA (FEVER) and HEADACHE (HEADACHES) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided. No concomitant medications of the patient were reported.
Patient reported sweating and dizziness followed by rapid heart rate and labored breathing. After consent pharmacist administered oral Benedryl. Patient reported immediate relief. Pharmacist called EMT services, EMT reviewed patient vitals and offered emergency transport. Patient denied transport and self medicated with oral Benedryl. Symptoms resolved and did not return.
Felt lethargic; Hot and burning; Knot in the same arm of injection; Was itchy; Hives appeared on her left arm; Body aches; Red; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy) and VACCINATION SITE URTICARIA (Hives appeared on her left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, LETHARGY (Felt lethargic), VACCINATION SITE WARMTH (Hot and burning), VACCINATION SITE MASS (Knot in the same arm of injection), VACCINATION SITE PRURITUS (Was itchy), VACCINATION SITE URTICARIA (Hives appeared on her left arm), MYALGIA (Body aches) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Information has been received from a consumer concerning her 17 year old daughter with asthma and no drugs allergies, who on 06-JUL-2005 was vaccinated with a first dose of VARIVAX (Merck) (lot # 649274/0896P).  The patient received a second dose of VARIVAX (Merck) (lot # 649740/0221R) on 24-AUG-2005.  Concomitant therapy included ADVIL and albuterol.  The patient failed to developed proper titers after receiving the 2 VARIVAX (Merck) doses.  The patient has no symptoms.  The patient had a blood work done on 15-JUN-2009.  It was also reported that the patient received a first dose of RECOMBIVAX HB (MSD) (lot # 643755/0706M), a second dose of RECOMBIVAX HB (MSD) (lot # 643683/0705M) and a third dose of RECOMBIVAX HB (MSD) (lot # 643366/0054N) on 11-SEP-2002, 31-OCT-2002 and on 24-JUN-2003 respectively.  The patient also failed to develop proper titers after these doses.  This is one of two reports concerning the same patient.  No further information is available.
By 6pm there was severe pain in my arm and head. Fatigue. Symptoms worsened the next day, followed by fever, chills, body aches, and pain in the shoulder, neck, and head by the 2nd day. Fever of 103.1 that persisted for 10 hours before breaking. Migraines and stomach upset still persisting. It is 13:10 on day 2.
The night after receiving my first shot my ears have rang a very loud high pitch all the time there is never a break from this. I also reported this everytime I was phoned..
Swelling, redness, slight pain/itchiness at injection site - advised on 4/6 to treat with cool compress/ice pack and oral Benadryl (no outcome yet - need to apply treatment/s)
Patient had influenza vaccine injection (unknown name/brand/manufacturer/lot number) in left arm at her workplace.
Mom received flu vaccine here with son on 12-8-15. She called today due to prolonged pain and swelling at site. Advised she see her doctor. He dx as an allergic reaction to the preservative in the vaccine.
Received SHINGRIX vaccine on 10/2/19 and on 10/4/19 the injection site was extremely red, swollen, painful, and warm. He came into the pharmacy and was told to go to urgent care to be seen. He returned to the pharmacy later that day with a prescription for an antibiotic and a diagnosis of infection.
about 9 days after my booster (moderna), patient developed dermatographia, tightness in throat, stomach issues.   NOTE: i am providing a link to a website where people in the comments have all had a similar reaction. MANY MANY PEOPLE!
A pt was vaccinated with the Pfizer COVID-19 vaccine on the 4th of July (I will look up and confirm the date she received it when I get back to work).  I think the pt forgot that she received a dose already. We looked through the pt?s Vaccine Consent Form and she marked as no to question #6 ("Have you had the vaccine(s) you are receiving today before?").   One of our pharmacists had to look in the registry to find out that she had received the Moderna COVID-19 vaccine in March at a local fire department.  And also when pts come in to get a COVID-19 vaccine, we verify with pts if it is the 1st or 2nd in order to choose the appropriate vaccines.  At this time, no additional doses of either product are recommended if a pt received a mixed series of different mRNA COVID-19 vaccine products.  We printed out the info from the CDC website and the pt will come in to get the info.
Vaccine Administered after beyond use date (1/28/2023). Staff re-trained on proper storage and handling and process reviewed to ensure safe administration in the future. Moderna contacted regarding administration error for stability information. Patient will be contacted and offered re-vaccination according to CDC recommendations.
I developed small hives on both my arms. The right arm was worse. My whole body started itching. I took benadryl, it didn't help. Saw my doctor on 3/22/10 at 9:00 AM. Prescribed Allegra twice daily. 3/24/10 hives are finally starting to receed. Body still itches.
With in 30 minutes my lower R shot arm developed hive like bumps, they did not itch. There was no reaction around the shot area. Within an hour I got bad chills and a very stuffy head. Next day I began to feel nauseous. On Sunday I became extremely tired, still feeling a little nauseous, through Monday, Today Tuesday, I don't feel nauseous, still tired and now have the start of a sore throat, hive like bumps are still on my lower shot arm and have not spread.
This spontaneous report was received from a registered nurse refers to a 1 month old patient with no pertinent medical history and no drug allergy. On 19-SEP-2012, the patient was vaccinated intramuscularly with 0.5 ml RECOMBIVAX HB (Lot# reported as 0293AE, expiry 01-SEP-2014). There was no concomitant medications. On 21-SEP-2012, a day after vaccination with RECOMBIVAX HB the patient experienced bilateral hands and feet swelling, with "head to toe" fine red rash. The patient sought medical attention and was evaluated in the office. No treatment has been prescribed at the time of the report. No lab test was done. The outcome of events was reported as not recovered. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 22-JUL-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient stated she was coming in for 2nd booster. Staff did not verify that patient had covid vaccine card and gave patient "second booster". Patient presented back to office with card and had received 2nd booster at local pharmacy.
This spontaneous report was received from a registered nurse reporting on a 16-month-year old patient of unknown gender. No information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On 14-FEB-2017, the patient was vaccinated with improperly stored dose of VARIVAX injection (dose, frequency and route of administration were not reported, lot # either L050561 with expiration date of 14-DEC-2017 or M019841 with expiration date of 20-APR-2018), for prophylaxis. The Merck (MRK) sterile diluent (lot # and expiration date were not reported) used to reconstitute the VARIVAX was properly stored. The temperature excursion ranged from 6 to 14 degrees Fahrenheit and lasted for 30 minutes. It occurred once on 03-FEB-2017, and was detected by a Digital Data Logger. There was no previous excursion reported. No adverse effects were reported. This was one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA010916: US-009507513-1704USA009837: Original Case : 1704USA009837
Patient recently discharged from Hospital for COVID pneumonia.  Patient symptoms did not improve and came to our faciliy on 9/3.  Patient's respiratory status deteriorated.  Family consented to DNR.  Patient expired 9/15/21.
Patient reports excruciating pain during the vaccine, as well as pain since the vaccine was administered. She reports 'golf-ball' sized swelling in her left deltoid.